BenQ Medical Technology (4116) - Total Liabilities

Latest as of June 2025: NT$3.14 Billion TWD ≈ $99.02 Million USD

Based on the latest financial reports, BenQ Medical Technology (4116) has total liabilities worth NT$3.14 Billion TWD (≈ $99.02 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BenQ Medical Technology (4116) cash conversion ratio to assess how effectively this company generates cash.

BenQ Medical Technology - Total Liabilities Trend (2017–2024)

This chart illustrates how BenQ Medical Technology's total liabilities have evolved over time, based on quarterly financial data. Check BenQ Medical Technology liquidity resilience to evaluate the company's liquid asset resilience ratio.

BenQ Medical Technology Competitors by Total Liabilities

The table below lists competitors of BenQ Medical Technology ranked by their total liabilities.

Company Country Total Liabilities
Eslite Spectrum
TWO:2926
Taiwan NT$15.35 Billion
Creas F&C Co.Ltd
KQ:110790
Korea ₩454.06 Billion
Endurance Gold Corp
V:EDG
Canada CA$687.19K
Cs Holdings
KO:000590
Korea ₩31.86 Billion
BEST Inc
NYSE:BEST
USA $6.13 Billion
Vbt Yazilim AS
IS:VBTYZ
Turkey TL1.15 Billion
HeiTech Padu Bhd
KLSE:5028
Malaysia RM520.55 Million
Thunderbird Entertainment Group Inc
V:TBRD
Canada CA$114.12 Million

Liability Composition Analysis (2017–2024)

This chart breaks down BenQ Medical Technology's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BenQ Medical Technology (4116) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.58 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.98 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.60 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BenQ Medical Technology's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BenQ Medical Technology (2017–2024)

The table below shows the annual total liabilities of BenQ Medical Technology from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 NT$2.97 Billion
≈ $93.68 Million
+17.45%
2023-12-31 NT$2.53 Billion
≈ $79.77 Million
+52.38%
2022-12-31 NT$1.66 Billion
≈ $52.35 Million
+94.22%
2021-12-31 NT$855.51 Million
≈ $26.95 Million
+26.22%
2020-12-31 NT$677.80 Million
≈ $21.35 Million
+15.81%
2019-12-31 NT$585.25 Million
≈ $18.44 Million
-0.69%
2018-12-31 NT$589.30 Million
≈ $18.57 Million
+23.85%
2017-12-31 NT$475.80 Million
≈ $14.99 Million
--

About BenQ Medical Technology

TWO:4116 Taiwan Medical Instruments & Supplies
Market Cap
$56.09 Million
NT$1.78 Billion TWD
Market Cap Rank
#21444 Global
#1316 in Taiwan
Share Price
NT$39.95
Change (1 day)
+1.40%
52-Week Range
NT$39.10 - NT$51.70
All Time High
NT$116.31
About

BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the… Read more